All news

Evotec stock: JPMorgan disclosure adds focus before results

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

JPMorgan Chase & Co. disclosed a changed combined position in Evotec ahead of the company's first nine-month 2026 results and business update on November 5. The disclosure, published on October 29, shows JPMorgan's combined position at 3.86 percent of voting rights attached to shares and 2.69 percent through instruments.

Read original source

EVO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.